Current Strategies in Cardiovascular Biomaterial Functionalization
Open Access
Abstract
Prevention of the coagulation cascade and platelet activation is the foremost demand for biomaterials in contact with blood. In this review we describe the underlying mechanisms of these processes and offer the current state of antithrombotic strategies. We give an overview of methods to prevent protein and platelet adhesion, as well as techniques to immobilize biochemically active molecules on biomaterial surfaces. Finally, recent strategies in biofunctionalization by endothelial cell seeding as well as their possible clinical applications are discussed.Keywords
This publication has 103 references indexed in Scilit:
- Contact activation of blood-plasma coagulationBiomaterials, 2009
- Bioactivity and Platelet Adhesion Study of a Human Thrombomodulin-Immobilized Nitinol SurfaceJournal of Biomaterials Science, Polymer Edition, 2009
- Cell‐type specific evaluation of biocompatibility of commercially available polyurethanesJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2008
- The elusive physiologic role of Factor XIIJournal of Clinical Investigation, 2008
- Capture of Flowing Endothelial Cells Using Surface-Immobilized Anti-Kinase Insert Domain Receptor AntibodyTissue Engineering Part C: Methods, 2008
- Platelet and endothelial adhesion on fluorosurfactant polymers designed for vascular graft modificationJournal of Biomedical Materials Research Part A, 2008
- The influence of biomaterials on endothelial cell thrombogenicityBiomaterials, 2007
- Fabrication of a phospholipid membrane-mimetic film on the luminal surface of an ePTFE vascular graftBiomaterials, 2006
- Randomized comparison of carbon ion–implanted stent versus bare metal stent in coronary artery disease: The Asian Pacific Multicenter Arthos Stent Study (PASS) trialAmerican Heart Journal, 2005
- Effect of heparin–pva hydrogel on platelets in a chronic canine arterio‐venous shuntJournal of Biomedical Materials Research, 1989